References
- Asaka Y, Ohsaki A, Kubota T, Matsukawa Y, Satomi Y, Nishino H (1992): 5,7, 3,'4'-Teterahydroxy-3-methoxyflavone, a potent antitumor promoter isolated from Guaphalium indicum. Kyoto-fruitsu lka daigaku zasshi 101: 353–359.
- Baker FJ, Breach MR (1980): Medical Microbiological Tech-niques. Butter Worth's London, p. 496.
- Bharani A, Ganguly A, Bhargava KD (1995): Salutary effect of Terminalia arjuna in patients with severe refractory heart failure. Int J Cardiol 49: 191–199.
- Dwivedi S, Agarwal MP (1994): Antianginal and cardioprotec-tive effects of Terminalia arjuna, an indigenous drug in coronary artery diseases. J Assoc Physicians of India 42: 278–289.
- Dwivedi S, Udupa N (1989): Terminalia arjuna. Pharmacog-nosy, phytochemistry, pharmacology and clinical use: A review. Fitoterapia 60: 413–420.
- Haval RJ, Rapaport E (1995): Management of primary hyper-lipideamia. N Engl J Med 332: 1491–1498.
- Hertog MGL, Hollman PCH, Katan MB, Kromhout D (1993): Intake of potentially anticarcinogenic flavonoids and their determints in adults in the Netherlands. Nutr Cancer 20: 21–29.
- Hertog MGL, Hollman PCH, Katan MB (1992): Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. JAgr Food Chem 40: 2379–2383.
- Huang MT, Wood AW, Newmark HL, Sayer JM, Yagi H, Jerina DM, Conney AH (1983): Inhibition of mutagenicity of bay region diol epoxides of polycyclic aromatic hydrocar-bons by phenolic plant flavonoids. Carcinogenesis 4: 1631–1638.
- Hugo WB, Rrussel AD (1977): Pharmaceutical Microbiology. Oxford, London, Blackwell Scientific Publications, p. 165.
- JaM V, Poonia A, Agarwal RP, Panwar RB, Kochar DK, Misra SN (1992): Effect of Terminalia arjuna in patients of angina pectoris. Ind Med Gazette (New Series) 36: 56–59.
- Jovanovic SV, Steenken S, Tosic M, Marjanomic B, Simic MG (1994): Flavonoids as antioxidants. J Amer Chem Soc 116: 4846–4851.
- Matthew KM (1981–1983): The Flora of Tamil Nadu Carnatic: Part I-III. Madras, Diocesan Press, pp. 689–1540.
- McCracken WA, Cawson RA (1983): Clinical and Oral Micro-biology. New York, Hemispher Publishing Corporation, p. 512.
- McKane L, Kandel J (1986): Microbiology — Essential and Applications. New York, McGraw-Hill Book Company, p. 335.
- Meyer T, Regenass U, Fabro D, Alteri E, Rosel J, Muller M, Caravatti G, Matter A (1989): A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C and in vitro anti-proliferate as well as in vivo anti-tumor activity. Int J Cancer 43: 851–856.
- Middleton E, Jr, Fujiki H, Savliwala M, Drzewiecki G (1987): Tumor promotor induced basophil histamine release. Effect of selected flavonids. Biochem Pharmacol 36: 2048–2052.
- Nair S, Nagar R, Gupta R (1996): Dietary anti-oxidant pheno-lics and flavonoids in coronary heart diseases. Ind Heart J 48: 545.
- Pathak SR, Upadhyaya L, Singh RN (1990): Effect of Terminalia arjuna on lipid profiles of rabbit fed hypercholesterolemic diet. Int J Crude Drug Res 28: 48–51.
- Pharmacopoeia of India (1955): Government of India Press, New Delhi, p. 450.
- Shaila HP, Udupa AL, Udupa SL (1995): Preventive action of Terminalia beterica in experimentally induced atheroscle-rosis. Int J Cardiol 49: 101–106.
- Singh N, Kapur KK, Singh SP, Shanker K, Sinha JN, Kohli RP (1982): Mechanism of cardiovascular action of Terminalia arjuna. Planta Med 45: 102–104.
- Tiwari AK, Gode JD, Dubey GP, (1990): Effect of Terminalia arjuna on lipid profiles of rabbits fed hypercholesterolemic diet. Int J Crude Drug Res 28: 43–47.
- Vaidya AB (1994): Terminalia arjuna in cardiovascular therapy. J Assoc Physicians India 42: 218–282.